
Mayo Clinic Cancer Center announced on Tuesday, Aug. 31, that it is following recommendations from the National Comprehensive Cancer Network that encourage cancer patients to receive a third dose of a messenger RNA COVID-19 vaccine. The Moderna and Pfizer COVID-19 vaccines are messenger RNA vaccines.
If patients were vaccinated with the Johnson & Johnson COVID-19 vaccine, no third dose is recommended at this time. The Johnson & Johnson COVID-19 vaccine is an adenovirus vaccine ― not a messenger RNA vaccine.
“The updated guidelines for cancer patients from NCCN are based on the latest data and approvals from the FDA (Food and Drug Administration) and CDC (Centers for Disease Control and Prevention) regarding administration of a third messenger RNA vaccine dose for cancer patients and immunocompromised people,” says Robert McWilliams M.D., a medical oncologist. Dr. McWilliams is chair of Mayo Clinic’s Cancer Center Practice Committee.
Here’s who should receive a third dose of a messenger RNA COVID-19 vaccine:
Review the updated vaccination guidelines for cancer patients on the National Comprehensive Cancer Network website and visit the Mayo Clinic website for more information.
Based on a city where the mountain meets the sea and where antique houses line the streets, my mind is free to wonder, to wander and to write.
Join our mailing list to be on the front lines of healthcare , get exclusive content, and promos.